ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "work"

  • Abstract Number: 1422 • ACR Convergence 2025

    Assessment of difficulties, modifications and use of work adaptations in patients with axial spondyloarthritis: validation of the DificuLtAx and ModAL questionnaires

    mariana benegas1, Maria Victoria Martire2, Leandro ferreryra3, Hernan Maldonado4, Carla Airoldi5, Luciana Casalla6, Joan Manuel Dapeña7, Etel Saturansky8, Eliana Serrano7, Julieta Morbiducci9, Aixa Lucia Merce10, Natalia Zamora11, Javier Federico Flores Trejo12, Fernando Sommerfleck13, Emilio Buschiazzo14, Hernan Molina15, Cecilia Castro16 and Romina Nieto17, 1sanatorio Mendez, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 2Hospital San Roque, La plata, Buenos Aires, Argentina, 3HIBA, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 4, Hospital San Antonio de Padua, Rio cuarto, Cordoba, Argentina, 5Hospital Provincial de Rosario, Rosario, Santa Fe, Argentina, 6Centro medio GENEA, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 7Sanatorio Dr Julio Méndez, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 8Sanatorio Méndez, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 9Hospital General de Agudos Bernardino Rivadavia, Capital Federal, Ciudad Autonoma de Buenos Aires, Argentina, 10Hospital General de Agudos Bernardino Rivadavia, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 11HIGA San José, pergamino, Buenos Aires, Argentina, 12Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 13Sanatorio Julio Mendez, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 14, Hospital Sr. del Milagro, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 15Instituto CER, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 16Hospital Z.G.A Dr. Isidoro Iriarte de Quilmes, Quilmes, Buenos Aires, Argentina, 17Centro Regional de Enfermedades Autoinmunes y Reumáticas, GO-CREAR, Rosario, Argentina, Rosario, Argentina

    Background/Purpose: DificuLtAR and ModAL, two spanish-language questionnaires that assess work difficulties and workplace adaptations, were originally developed and validated for rheumatoid arthritis (RA). Their performance…
  • Abstract Number: 1077 • ACR Convergence 2025

    Health literacy and work status in people with inflammatory arthritis: a cluster analysis in a national cohort

    Mrinalini Dey1, Sam Norton2, Andrew Cope2, MAYA BUCH3, Richard Osborne4, James Galloway2 and Elena Nikiphorou2, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2King's College London, London, United Kingdom, 3UNIVERSITY OF MANCHESTER, MANCHESTER, United Kingdom, 4La Trobe University, Melbourne, Victoria, Australia

    Background/Purpose: Work status and employment can be impacted in people with inflammatory arthritis (IA). We aimed to assess the association between health literacy and work…
  • Abstract Number: 0525 • ACR Convergence 2025

    Cost-of-Illness Among Newly Diagnosed Patients with Psoriatic Arthritis in Sweden

    Sofia Wittgren1, Sofia Exarchou2, Daniela Di Giuseppe3, Ulf Lindström4, Tor Olofsson1, Lennart T. H. Jacobsson4, Johan Askling3 and Johan Karlsson Wallman1, 1Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, Skane Lan, Sweden, 2Lund University, Åkarp, Skane Lan, Sweden, 3Karolinska Institutet, Department of Medicine Solna, Clinical Epidemiology Division, Stockholm, Stockholms Lan, Sweden, 4Gothenburg University, Sahlgrenska Academy, Department of Rheumatology and Inflammation Research, Gothenburg, Vastra Gotaland, Sweden

    Background/Purpose: Up-to-date information on the cost-of-illness of psoriatic arthritis (PsA) is important for healthcare/social insurance system budgeting and to highlight unmet needs in PsA care.…
  • Abstract Number: 0179 • ACR Convergence 2025

    Digital Divide in Rheumatology: Patterns of Technology and AI Adoption Across Generations of Specialists

    CARLA F DIONELLO1, ANA F PADUA2, Claudia Marques3, BRUNA L PORTO4, LEONARDO R CAMPOS5, RODRIGO OLIVEIRA6, GUSTAVO GM BALBI7, RODRIGO LUPPINO-ASSAD6, YURE G AZEVEDO8, LUIZ F DIPE9, BRUNO BORDALLO5, Cleandro Pires10, Licia Maria Henrique da Mota10 and PAULA MONTINA10, 1FEDERAL UNIVERSITY OF RIO DE JANEIRO - UFRJ, RIO DE JANEIRO, Rio de Janeiro, Brazil, 2SANTA CASA MG, BELO HORIZONTE, Minas Gerais, Brazil, 3Hospital das Clinicas - Universidade Federal de Pernambuco - UFPE, Recife, Pernambuco, Brazil, 4UNIVATES, SÃO LEOPOLDO, Rio Grande do Sul, Brazil, 5UFF, Rio de Janeiro, Rio de Janeiro, Brazil, 6FMRP-USP, Ribeirão Preto, Sao Paulo, Brazil, 7UFJF, JUIZ DE FORA, Minas Gerais, Brazil, 8SCR, SOBRAL, Ceara, Brazil, 9GRUPO AMIL, SÃO PAULO, Sao Paulo, Brazil, 10UNB, Brasilia, Distrito Federal, Brazil

    Background/Purpose: The integration of digital tools and artificial intelligence (AI) in rheumatology practice has advanced rapidly. However, disparities in adoption across generations of specialists remain…
  • Abstract Number: 2555 • ACR Convergence 2025

    Ergonomic Modifications: Findings From the Making it WorkTM Systemic Sclerosis Program

    Janet Poole1, Mary Thelander1 and Kristine Carandang2, 1University of New Mexico, Albuquerque, NM, 2Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA

    Background/Purpose: Work disability in people with systemic sclerosis (SS) increases substantially from diagnosis to three years after disease onset.  Ergonomic modifications help people with physical,…
  • Abstract Number: 0350 • ACR Convergence 2024

    Piloting an Adaptation of the Making It Work Program for Systemic Sclerosis: Promising Effects on Job Related Self-efficacy and Risk of Work Disability

    Janet Poole1, Kristine Carandang2, Mary Thelander Hill1, Jessica Salazar1, Anna Koch3, Timothy Dionne1 and Diane Lacaille4, 1University of New Mexico, Albuquerque, NM, 2Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA, 3Comfy Couch Counseling LLC, Albuquerque, NM, 4Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Although work disability presents a substantial burden for people with systemic sclerosis (SS), there are no tailored programs that aim to support their employment.…
  • Abstract Number: 0561 • ACR Convergence 2024

    Axial Spondyloarthritis Patients with Comorbid Fibromyalgia Feel Worse, Work Less and More Often Try Multiple Biological DMARDs − Results from a Population-Based Cohort

    Annie Brink1, Elisabeth Mogard2, Elisabet Lindqvist2, Jonas Sagard2, Johan Karlsson Wallman1 and Tor Olofsson2, 1Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Skane Lan, Sweden, 2Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Sweden

    Background/Purpose: A growing arsenal of biologic/targeted synthetic DMARDs often makes inflammation control an attainable target in axial spondyloarthritis (axSpA). Yet, many patients keep suffering from…
  • Abstract Number: 0587 • ACR Convergence 2024

    Achieving Stringent Disease Control Criteria Was Associated with Greater Work Productivity Improvements in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab

    William Tillett1, Dafna Gladman2, Laure Gossec3, Jason Eells4, Patrick Healy5, Barbara Ink4, Nikos Lyris4 and Jessica A Walsh6, 1Royal National Hospital of Rheumatic Diseases; Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Sorbonne Université, Paris, France, 4UCB Pharma, Slough, United Kingdom, 5UCB Pharma, Morrisville, NC, 6Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, UT

    Background/Purpose: Psoriatic arthritis (PsA) negatively impacts patients’ physical health and functional ability, which can contribute to reduced work productivity.1,2 We examined the association between achieving…
  • Abstract Number: 1074 • ACR Convergence 2024

    Bending the Curve on Inbox Bloat: A Patient Portal Project to Mature-the-Message via Nurse Triage to Reduce Provider Inbox Time

    Christie Bartels1, Sancia Ferguson2, Carmen Campbell1, Lori Zemlicka3, Amanda Weber3, Andrew Holt1 and Elizabeth R. Trowbridge4, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin, Madison, Madison, WI, 3UW Health Rheumatology, Madison, WI, 4Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Clinical demands have grown, in part, from rising use of patient portals, while traditional clinic nurse triage has focused on phone-based care. We sought…
  • Abstract Number: 1254 • ACR Convergence 2024

    The Impact of Eosinophilic Granulomatosis with Polyangiitis on the Health-Related Quality of Life of Patients and Their Ability to Work: Evidence from a Real-World Survey in Clinical Practice

    Robert Spiera1, Paul Dolin2, Anat Shavit2, Jennifer Rowell3, Chris Edmonds4, Josefine Persson5, Danuta Kielar6, Daniel Mascia7, James Siddall7, Tia Pennant7, Fritha Hennessy7 and Stephanie Y. Chen8, 1Scleroderma, Vasculitis, and Myositis Center, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 2BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom, 3Market Access and Pricing, AstraZeneca, Cambridge, England, United Kingdom, 4Market Access and Pricing, AstraZeneca, Gaithersburg, MD, 5Market Access and Pricing, AstraZeneca, Gothenburg, Sweden, 6Biopharmaceuticals Medicine, AstraZeneca, Cambridge, United Kingdom, 7Adelphi Real World, Bollington, United Kingdom, 8BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody-associated vasculitis that confers significant disease burden. This real-world study described the impact of…
  • Abstract Number: 1500 • ACR Convergence 2024

    Work-Related Disability and Function in Systemic Lupus Erythematosus (SLE): Outcomes of an Exploratory Study from Different Canadian Centres

    Behdin Nowrouzi-Kia1, J. Antonio Avina-Zubieta2, Mary Fox3, William Shaw4, Maggie Ho5, Qixuan Li5, Catherine Ivory6, Paul Fortin7, Stephanie Keeling8, Jennifer Reynolds9, Derek Haaland10, Janet Pope11, Lily Lim12, Patti Katz13, Murray Urowitz14, Laura Patricia Whittall Garcia5, Dafna Gladman15 and Zahi Touma1, 1University of Toronto, Toronto, ON, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 3York University, Toronto, ON, Canada, 4University of Connecticut, School of Medicine, Farmington, CT, 5University Health Network, Toronto, ON, Canada, 6The Ottawa Hospital, Ottawa, ON, Canada, 7Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 8University of Alberta, Edmonton, AB, Canada, 9UBC, North Vancouver, BC, Canada, 10The Waterside Clinic, Oro Medonte, ON, Canada, 11University of Western Ontario, London, ON, Canada, 12University of Manitoba, Winnipeg, MB, Canada, 13UCSF, San Rafael, CA, 14Self employed, Toronto, ON, Canada, 15University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) has a significant and long-lasting impact on work outcomes, is a source of long-lasting work disability, and presents challenges with…
  • Abstract Number: 1741 • ACR Convergence 2024

    Implementing Strengths-Based, Positive Approaches Within Rheumatology Fellowship Training: A Realist Evaluation of Appreciative Inquiry-Based Interventions

    Alick Feng1, Manish Suneja1 and Bharat Kumar2, 1UNVERSITY OF IOWA HOSPITALS AND CLINICS, Iowa City, IA, 2University of Iowa Hospitals and Clinics, Iowa City, IA

    Background/Purpose: Appreciative Inquiry (AIn) is a strengths-based organizational framework to promote engagement and change.  It has shown promise in graduate medical education (GME) settings but…
  • Abstract Number: 1941 • ACR Convergence 2024

    No Show QI at Hoxworth Rheumatology Clinic: Evaluating the Impact of Live Telephone Calls Combined with Automated Reminders

    Nicola Jackson1, kim Nguyen2, Tien Nguyen3, Meg James3 and Avis Ware4, 1University of Cincinnati, Blue Ash, 2Trihealth Hospital, Cincinnati, 3University of Cincinnati, Cincinnati, 4University of Cincinnati, Cincinnati, OH

    Background/Purpose:  Patient no-show and cancellation rates are long-standing problems in the healthcare system, affecting patient outcomes, revenue, system efficiency, and resource utilization. At the Hoxworth…
  • Abstract Number: 2322 • ACR Convergence 2024

    Predictors of Work Impairment and Absence Amongst People with Psoriatic Arthritis (PsA) – Evidence from the British Society for Rheumatology PsA Register (BSR-PsA)

    Lili Xu1, Gareth Jones1, Ovidiu Rotariu1, Philip S. Helliwell2, Stefan Siebert3, Rosemary Hollick1 and Gary Macfarlane1, 1University of Aberdeen, Aberdeen, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 3School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: People with PsA often report that their condition affects their ability to work. Poor work outcomes, such as work impairment, absence or leaving work,…
  • Abstract Number: 2416 • ACR Convergence 2024

    The Impact of Active Lupus Nephritis on Work Productivity in Patients from a Latin American Lupus Cohort

    Romina Nieto1, Rosana Quintana2, Diana Carolina Fernández Ávila3, Rosa Serrano Morales4, Guillermina Harvey5, Lucia Hernandez6, Karen Roberts7, Luis Catoggio8, Gisela Subils9, Carla Gobbi10, Bordón Florencia Juliana11, Pablo David Ibáñez Peña12, Leonel Ariel Berbotto13, María C. Bertolaccini14, Diego O. Riseni15, María De Los Ángeles Gargiulo16, Cecilia Pisoni17, Joaquín Martínez Serventi18, Emilio Buschiazzo19, Vitalina De Souza Barbosa20, ODIRLEI MONTICIELO21, Carolina Albanez de A. Da C. Andrade22, Francinne Machado Ribeiro23, Eloisa Bonfa24, Eduardo Borba24, Emília Sato25, Alexis Bondi Peralta26, Silvana Donoso27, Gustavo Aroca Martínez28, Hellen Medina28, Alex Echeverri29, Sebastián Molina-Rios30, Manuela Rubio31, Rafael López32, Mario Moreno33, Olga Lidia Vera Lastra34, Mario Pérez Cristóbal35, Carlos Núñez-Álvarez36, luis M Amezcua Guerra37, Ignacio García-Valladares38, Carlos Abud Mendoza39, Dionicio Galarza-Delgado40, Marcos Vázquez41, Astrid Paats42, Jorge N. Cieza Calderón43, Ana Mabel Quiroz Alva44, Roberto Muñoz Louis45, Carina Pizzarossa46, Adriana Carlomagno47 RV Gamboa-Cardenas48, Graciela Alarcon49, Urbano Sbarigia50, Federico Zazzetti51, Ashley Orillion52, Guillermo Pons-Estel1 and Bernardo Pons-Estel1, 1Centro Regional de Enfermedades Autoinmunes y Reumaticas. GO-CREAR, Rosario, Santa Fe, Argentina, 2Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, 3Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, Rosario, Argentina, 4Sanatorio Parque. Centro de Enfermedades Autoinmunes y Reumaticas del Grupo Oroao., Rosario, Argentina, 5Escuela de Estadística, Facultad de Ciencias Económicas y Estadística, Universidad Nacional de Rosario, Rosario, Argentina, Rosario, Argentina, 6Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), ROSARIO, Santa Fe, Argentina, 7Sección Reumatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 8Sección Reumatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;, Buenos Aires, Argentina, 9Hospital Italiano de Córdoba, Córdoba, Argentina, Córdoba, Argentina, 10Hospital Córdoba, Ciudad de Córdoba, Argentina, Córdoba, Argentina, 11Hospital Privado Universitario de Córdoba, Córdoba, Argentina, 12Hospital HIGA San Martín, La Plata, Argentina, La Plata, Argentina, 13Unidad de Enfermedades Autoinmunes, Hospital Escuela Eva Perón, Granadero Baigorria, Argentina, Granadero Baigorria, Argentina, 14Hospital Padilla, Tucumán, Argentina, Tucumán, Argentina, 15Hospital General de Agudos J.M. Ramos Mejía, Buenos Aires, Argentina, Buenos Aires, Argentina, 16Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina, Buenos Aires, Argentina, 17CEMIC, Buenos Aires, Argentina, 18Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires, Argentina, CABA, Argentina, 19Hospital Señor del Milagro, Salta, Argentina, Salta, Argentina, 20Hospital das Clínicas, Universidade Federal de Goias, Goias, Brazil, Goiânia, Brazil, 21HOSPITAL DE CLINICAS DE PORTO ALEGRE, PORTO ALEGRE, Rio Grande do Sul, Brazil, 22Universidade Federal de Pernambuco, Pernambuco, Brazil, Pernambuco, Brazil, 23Hospital Universitario Pedro Ernesto, UERJ, Rio De Janeiro, Brazil, Rio de Janeiro, Brazil, 24Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 25Universidade Federal de Sao Paulo, São Paulo, SP, Brazil, 26Hospital del Salvador, Santiago, Chile, 27Clinical Laboratory Hospital Regional Libertador Bernardo O'Higgins, Rancagua, Chile, Rancagua, Chile, 28Universidad Simón Bolivar, Barranquilla, Colombia, Barranquilla, Colombia, 29Fundación Valle del Lili, Unidad de Reumatología, Colombia, Reumatología, Colombia, 30Facultad de Medicina, Universidad Nacional de Colombia. Hospital Universitario Nacional, Bogotá, Colombia, 31Centro de Estudios de Reumatología & Dermatología SAS, Bogotá, Colombia, 32Servicio de Reumatología. Hospital Luís Vernaza, Guayaquil, Ecuador, Guayaquil, Ecuador, 33Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador, Guayaquil, Ecuador, 34División de Investigación en Salud, Hospital de Especialidades Dr. Antonio Fraga Mouret, CMN La Raza, CDMX, Mexico, 35Centro Médico Nacional Siglo XXI, CDMX, Mexico, IMMS, Mexico, 36Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, CDMX, Mexico, Mexico, Mexico, 37Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez., México, Mexico, 38Depto. de Inmunología y Reumatología, Hospital General de Occidente y Universidad de Guadalajara, Guadalajara, Mexico, Guadalajara, Mexico, 39Hospital Central Dr. Ignacio Morones Prieto, SLP, México, SLP, Mexico, 40UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 41Hospital de Clínicas I, Asunción, Paraguay, Asuncion del Paraguay, Paraguay, 42Hospital de Clínicas I, Asunción, Paraguay, 43Hospital Nacional Edgardo Rebagliatti Martins, Lima, Perú, Lima, Peru, 44Hospital Cayetano Heredia, Lima, Perú, Lima, Peru, 45Hospital Docente Padre Billini, Santo Domingo, República Dominicana, Santo Domingo, Dominican Republic, 46Clínica Médica C, Hospital de Clínicas, UDELAR, Montevideo, Uruguay, 47Grupo de Investigación de EAIS y Reumatológicas, Montevideo, Uruguay, 48Universidad Científica del Sur, Lima, Lima, Peru, 49The University of Alabama at Birmingham, Birmingham, AL, 50Johnson & Johnson Innovative Medicine, Brussels, Belgium, 51Johnson & Johnson Innovative Medicine, Horsham, PA, PA, 52Johnson & Johnson Innovative Medicine, Spring House, PA

    Background/Purpose: The Latin American Group for the Study of Lupus (GLADEL) 2.0 is an observational prevalent and incident cohort of patients with systemic lupus erythematosus…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology